Drug Patents owned by Serenity Pharms Llc

1. List of Noctiva drug patents

NOCTIVA's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7579321 SERENITY PHARMS LLC Pharmaceutical compositions including low dosages of desmopressin
May, 2023

(28 days ago)

US7405203 SERENITY PHARMS LLC Pharmaceutical compositions including low dosages of desmopressin
May, 2023

(28 days ago)

US7799761 SERENITY PHARMS LLC Pharmaceutical compositions including low dosages of desmopressin
Sep, 2024

(1 year, 3 months from now)

US9539302 SERENITY PHARMS LLC Safe desmopressin administration
Jun, 2030

(7 years from now)

US11419914 SERENITY PHARMS LLC Safe desmopressin administration
Jun, 2030

(7 years from now)

Do you want to check out NOCTIVA patents from before 2022?

Drugs and Companies using DESMOPRESSIN ACETATE ingredient

Market Authorisation Date: 03 March, 2017

Treatment: A method of treating nocturia due to nocturnal polyuria in adults; Treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void by inducing an antidiuretic e...

Dosage: SPRAY, METERED;NASAL

More Information on Dosage

NOCTIVA family patents

26

United States

8

Australia

8

Japan

7

European Union

6

China

5

Korea, Republic of

5

Denmark

5

Spain

4

Portugal

4

Poland

3

Canada

3

Russia

3

Mexico

3

Argentina

3

Brazil

EA

2

EA

2

Israel

IB

2

IB

2

New Zealand

2

Uruguay

2

Singapore

2

Germany

2

South Africa

1

Croatia

1

Malaysia

1

Austria

1

Ukraine

1

Norway

1

United Kingdom

1

Hong Kong

1

Slovenia

1

Taiwan

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic